Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Spironolactone safe, effective option for women with hidradenitis suppurativa
“Combining different treatment options that target different pathophysiologic factors is usually required to achieve adequate disease control in...
News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
The agency cited concerns related to an inspection of a third-party contract manufacturer.
News
Does the number of primary melanomas affect survival?
To compare 10-year melanoma-specific mortality and overall mortality between people with multiple primary melanomas and a single primary melanoma...
News
A glimpse at devices designed to tackle cellulite
Development of RAP and targeted verifiable subcision have helped clinicians better understand the makeup of septa, Dr. Ortiz said.
News
Study spotlights paucity of black dermatologists in academia
“Greater efforts are needed to recruit Black dermatology graduates into academic faculty positions,” the authors concluded.
News
‘Old school’ laser resurfacing remains an effective option for rejuvenation
Key drawbacks of fully ablative resurfacing include significant downtime and extensive wound care, “so it’s not for everybody,” Dr. Arisa E. Ortiz...
News
Thread lifts an option for noninvasive facial tightening
“It’s tissue repositioning; it is not a facelift.”
News
Severe psoriasis linked to a higher risk for heart disease, study confirms
“We should diagnose and actively search for microvascular dysfunction in patients with psoriasis, as this population is at particularly high risk...
News
European Commission grants approval of ritlecitinib for severe alopecia areata
In June of 2023, ritlecitinib was approved by the FDA for treatment of severe alopecia areata in people ages 12 and older in the United States.
News
Combining lasers: A recipe for maximizing results and patient satisfaction
The order of device use also matters.
News
When treating scars, ‘rehabilitation’ is the goal, not perfection
Most scars respond best to treatments with ablative and nonablative fractional lasers tuned to gentle settings, according to Victor Ross, MD.
News
CHMP recommends marketing of biologic for atopic dermatitis
Most adverse events across the three pivotal studies were mild or moderate.
News
Hyperbaric oxygen therapy beneficial for calciphylaxis?
Although intravenous sodium thiosulfate is considered standard care in the treatment of calciphylaxis, HBOT has been reported to have beneficial...
News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.
News
Skin has different daytime and nighttime needs, emerging circadian research suggests
Photoreceptive molecules known as opsins also appear to play a role in regulating the skin’s clock.